We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.34B
AUM Growth
-$123M
Cap. Flow
-$153M
Cap. Flow %
-11.43%
Top 10 Hldgs %
26.37%
Holding
215
New
22
Increased
46
Reduced
51
Closed
31

Top Buys

Rank Stock Value
1
IMCR icon
Immunocore
IMCR
+$30.1M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$21.3M
3
BWXT icon
BWX Technologies
BWXT
+$17.1M
4
CBAY
Cymabay Therapeutics
CBAY
+$15.2M
5
IMGN
Immunogen Inc
IMGN
+$14M

Top Sells

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$37.8M
2
INSP icon
Inspire Medical Systems
INSP
+$37.4M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$35.7M
4
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$19.3M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 52.08%
2 Technology 13.86%
3 Industrials 8.87%
4 Energy 5.36%
5 Financials 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESTC icon
76
Elastic
ESTC
$7.81B
$3.96M 0.3%
48,715
+15,200
+45% +$1.04M
ODFL icon
77
Old Dominion Freight Line
ODFL
$44.9B
$3.94M 0.29%
19,280
-3,920
-17% -$793K
TOL icon
78
Toll Brothers
TOL
$14.5B
$3.92M 0.29%
53,014
+46,257
+685% +$3.65M
FSS icon
79
Federal Signal
FSS
$7.83B
$3.9M 0.29%
65,316
+11,183
+21% +$677K
AVGO icon
80
Broadcom
AVGO
$2.04T
$3.74M 0.28%
45,020
-81,490
-64% -$7.06M
MGPI icon
81
MGP Ingredients
MGPI
$375M
$3.68M 0.27%
34,896
-11,349
-25% -$1.29M
ELF icon
82
e.l.f. Beauty
ELF
$5.81B
$3.65M 0.27%
33,196
-8,305
-20% -$1.01M
BXSL icon
83
Blackstone Secured Lending
BXSL
$5.72B
$3.64M 0.27%
133,151
+100,000
+302% +$2.77M
BRBR icon
84
BellRing Brands
BRBR
$1.34B
$3.6M 0.27%
87,367
-79,873
-48% -$3.06M
HCP
85
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$3.59M 0.27%
157,188
-385
-0.2% -$10.5K
VC icon
86
Visteon
VC
$2.78B
$3.58M 0.27%
25,944
-1,722
-6% -$248K
COTY icon
87
Coty
COTY
$2.48B
$3.49M 0.26%
318,493
– –
GLBE icon
88
Global E Online
GLBE
$7.11B
$3.37M 0.25%
+84,851
New +$3.42M
EG icon
89
Everest Group
EG
$14.4B
$3.26M 0.24%
8,760
+268
+3% +$97.3K
GS icon
90
Goldman Sachs
GS
$303B
$3.24M 0.24%
10,000
– –
OLLI icon
91
Ollie's Bargain Outlet
OLLI
$4.94B
$3.23M 0.24%
+41,814
New +$3.05M
ACLS icon
92
Axcelis
ACLS
$4.33B
$3.15M 0.24%
19,342
+4,516
+30% +$794K
WIX icon
93
WIX.com
WIX
$2.52B
$3.08M 0.23%
33,590
+14,150
+73% +$1.26M
FDX icon
94
FedEx
FDX
$75.4B
$3.07M 0.23%
11,600
+5,474
+89% +$1.42M
BOX icon
95
Box
BOX
$4.6B
$3.07M 0.23%
126,608
-10,393
-8% -$297K
WT icon
96
WisdomTree
WT
$3.22B
$3.03M 0.23%
433,141
+234,095
+118% +$1.64M
JBI icon
97
Janus International
JBI
$757M
$2.85M 0.21%
+266,599
New +$2.94M
UBER icon
98
Uber
UBER
$153B
$2.85M 0.21%
61,897
– –
ONTO icon
99
Onto Innovation
ONTO
$15.3B
$2.77M 0.21%
21,760
+3,652
+20% +$434K
ASML icon
100
ASML
ASML
$669B
$2.76M 0.21%
4,697
– –
2 3
4
5 6

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Nicholas Investment Partners held 215 positions worth $1.34B, down 8.4% from $1.46B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nicholas Investment Partners withdrew a net $153M in Q3 2023, closing 31 positions and reducing 51 holdings. Its most notable exit was Apellis Pharmaceuticals, an estimated $37.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 54% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Sarepta Therapeutics worth $22.8M.

  • Nicholas Investment Partners's largest Q3 2023 buy was Sarepta Therapeutics: 188,085 shares worth $22.8M.
  • Nicholas Investment Partners added most to Immunocore in Q3 2023, an estimated $30.1M increase.
  • Nicholas Investment Partners's biggest Q3 2023 reduction was Karuna Therapeutics, Inc. Common Stock, cutting an estimated $12M.
  • Nicholas Investment Partners fully exited Apellis Pharmaceuticals in Q3 2023, selling an estimated $37.8M.
  • Nicholas Investment Partners's ten largest holdings make up 26% of its $1.34B portfolio in Q3 2023.
  • Nicholas Investment Partners opened 22 new positions and closed 31 in Q3 2023.
  • Nicholas Investment Partners's portfolio value fell 8.4% quarter-over-quarter to $1.34B.

Based on Nicholas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.